Baird Upgrades ResMed (RMD) to Outperform

January 13, 2022 2:53 AM EST
Get Alerts RMD Hot Sheet
Price: $226.99 -0.6%

Rating Summary:
    12 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 27 | New: 11
Join SI Premium – FREE

Baird analyst Mike Polark upgraded ResMed (NYSE: RMD) from Neutral to Outperform with a price target of $300.00 (from $270.00).

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $244.17 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Hot Upgrades, Upgrades